Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – Cyclic peptides
Patent
1990-06-01
1992-08-11
Cashion, Jr., Merrell C.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Cyclic peptides
C07K 512, A61K 3700
Patent
active
051380358
ABSTRACT:
The invention relates to cyclopeptide derivative usable as protease inhibitors and complying with formula: ##STR1## in which R.sup.1 is a halogen atom, e.g. bromine or a radical such as S.sup.+ R.sub.2.sup.4 X.sub.1/v.sup.v-, R.sup.2 is a hydrogen atom, an alkyl radical, a halogen atom or other groups, R.sup.3 is NH, O or S, Z comprises a peptide sequence Z.sup.1 and a group such that CO has one end connected to the aromatic nucleus and CO-AA is a radical derived fropm an amino acid having a specificity with respect to the protease to be inhibited.
REFERENCES:
Wakselmann et al., Chemical Abstracts, vol. 113, 1990 p. 721, Abst. No. 132827m.
Connert et al., Chem. Abst. vol. 114, 1990, Abst. No. 77553n.
Mor et al., Thrombosis Research, supplement VIII, 1988. pp. 35-44.
Chemical Abstracts, vol. 111, No. 11 Sep. 11, 1989, J. P. Mazaleyrat et al: "Directed enzymic hydrolysis of cyclopeptides containing an aminobenzoic acid residue", p. 319.
Chemical Abstract, vol. 109, No. 3, Jul. 18, 1988, J. P. Mazaleyrate et al.: "Synthesis and enzymic hydrolysis of cyclic peptides containing an anthranilic acid residue", p. 662.
Chemical Abstracts, vol. 109, No. 17, Oct. 24, 1988, M. Reboud-Ravaux et al: "Structural factors in the enzymic hydrolysis of cyclopeptides containing an o-or m-aminobenzoic acid residue", p. 320.
Chemical Abstracts, vol. 110, No. 5, Jan. 30, 1989, A. Mor et al.: "Susceptibility of plasminogen activators to suicide inactivation", p. 259.
Mazaleyrate Jean-Paul
Reboud-Ravaux Michele
Wakselman Michel
Cashion Jr. Merrell C.
Centre National de la Recherche Scientifique
Davenport A. M.
LandOfFree
Cyclopeptide derivatives usable as selective inhibitors with res does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopeptide derivatives usable as selective inhibitors with res, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopeptide derivatives usable as selective inhibitors with res will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-347485